Skip to main content

Philadelphia Agrees On $1B Opioid Settlement

Philadelphia Agrees On $1B Opioid Settlement

Philadelphia Agrees On $1B Opioid Settlement

Introduction

Philadelphia, along with other Pennsylvania counties, signed on a settlement that would churn out $1 billion for drug treatment and prevention, considering the opioid crisis in the state.

The officials agreed on the settlement after a brief argument where the mayor and the district attorney stated that the amount was too low and the 18-year payout schedule is too long for one of the most affected cities because of the drug epidemic.

According to the AG's office, Philadelphia would get at least $186 million as a share from the national opioid settlement of $26 billion. The mayor even stated that the city would get additional funds considering the city's devastation and residents' suffering.

The AG even informed that the drug distributors and manufacturer would start the payout of the settlement as soon as in April. It will help the government to set up programs to aware the drug-addicted people about the drawbacks and will also help to prevent the future opioid crisis. The agreement will even prevent greedy pharmaceutical companies' profit-oriented and deceptive opioid marketing.

Many cities and states across the U.S. have signed the $26 billion nationwide opioid settlement. The settlement amount will be paid by the drug manufacturer Johnson & Johnson (J&J) along with the three-drug distributors AmerisourceBergen Corp, McKesson Corp, and Cardinal Health, Inc. It will address the nationwide opioid crisis that has resulted in a large number of deaths and has devastated families and communities.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!